Excelya at UBIQ Events: 5th PV & Drug Safety Conference

Author: Galina Stamenova & Panagiota Grypioti
Published on: 06/05/2026

Estimated Reading Time: 4 min

UBIQ 2026 · Madrid Highlights

Introduction, from the floor of Madrid

The 5th edition of UBIQ events on pharmacovigilance once again brought the global drug safety community together in Madrid for several days of forward-thinking dialogue and hands-on exchange. From AI-enabled safety solutions to the operational realities of audit readiness and vendor oversight, the conference covered several key dimensions of modern PV practice, including AI-enabled safety solutions, signal management, inspection readiness, vendor oversight, and RMP lifecycle management. Excelya proudly returned as a sponsor for the third consecutive year, and our team came back energized, sharper, and ready to share what we learned. In this article, we break down our top takeaways from the event and explore why UBIQ events continue to set the benchmark for the pharmaceutical safety community.

Jump to Section

1Europe’s Trusted PV Community

2Excelya Top Insights from Madrid

3Looking Forward

4
FAQ

Europe’s Trusted PV Community

Why UBIQ Events Matter for the Pharmacovigilance Community

UBIQ has built a reputation as one of the most respected organizers of pharmacovigilance conferences in Europe. Each year, the community gathers Pharmacovigilance specialists, regulators, technology innovators, and operational leaders under one roof, creating a rare environment where strategic vision meets day-to-day execution. UBIQ has built a reputation as one of the most respected organizers of pharmacovigilance conferences in Europe. Each year, the community gathers Pharmacovigilance specialists, regulators, technology innovators, and operational leaders under one roof, creating a rare environment where strategic vision meets day-to-day execution.

“

UBIQ conferences serve as a unique meeting point where the industry exchanges emerging trends, shares best practices, and shapes the future of pharmaceutical safety

”

Every edition tackles key PV challenges, from AI adoption and regulatory expectations to operational excellence, while elevating the conversation. This is why Excelya has supported UBIQ pharma events for three consecutive years. Engaging directly with peers, regulators, and innovators reinforces our commitment to advancing standards in drug safety and pharmacovigilance. You can also explore our pharmacovigilance and safety expertise to see how we put these principles into practice for our clients.

Galina Stamenova, Hector De La Fouchardiere, Stephane Kocev, and Panagiota Grypioti at a UBIQ Events pharmacovigilance conference in Madrid.

From left to right: Galina Stamenova, Hector De La Fouchardiere, Stephane Kocev, and Panagiota Grypioti

Excelya Top Insights from Madrid

Top Takeaways from the UBIQ Pharmacovigilance Conference

AI is increasingly supporting pharmacovigilance processes

Discussions on AI focused on practical applications across selected PV activities, including case intake support, data review, signal detection support, and workflow optimization. Speakers emphasized that successful implementation depends on robust validation, governance, human oversight, and integration with existing PV quality systems.

Signal management and benefit-risk intelligence are evolving fast

Sessions highlighted how signal management teams are exploring AI-driven methods to support detection, prioritization, and evaluation, while maintaining scientific judgement and documented rationale. The key message was not to replace established PV principles, but to strengthen consistency, traceability, and timeliness in benefit-risk decision-making.

III

Continuous inspection readiness remains a core PV quality expectation

A recurring theme was the importance of maintaining inspection readiness as part of everyday PV operations. Rather than treating preparation as a last-minute activity, mature PV systems rely on ongoing documentation discipline, deviation and CAPA management, audit follow-up, quality reviews, and clear process ownership. Speakers reinforced that sustained readiness is not a new requirement, but a practical reflection of a well-functioning PV quality system .

PV vendor management requires sharper governance

Vendor oversight was reinforced as a critical element of PV governance, particularly as operating models become more distributed. Discussions highlighted the need for clearly defined responsibilities, well-maintained SDEAs/PVAs, documented oversight activities, performance monitoring, issue escalation, and inspection-ready evidence of control.

RMP lifecycle management remains central to proactive risk management

Risk Management Plans are no longer treated as static documents. Continuous RMP lifecycle monitoring, with regular review of effectiveness measures and changing risk profiles, was highlighted as essential. This ongoing approach helps keep safety strategies aligned with real-world evidence and regulatory expectations defined by bodies such as the European Medicines Agency

Above all, what stood out was the energy of the stand-up discussions. These exchanges gave attendees space to challenge ideas, swap real experiences, and build connections that will carry into their daily work long after the conference closed.

AI in Pharmacovigilance
RMP lifecycle monitoring
UBIQ
Safety

Looking Forward

Looking Forward: The Next Chapter in Drug Safety and Pharmacovigilance

The 5th edition of the conference reinforced that pharmacovigilance continues to evolve through a combination of technological innovation, strengthened governance, and sustained quality oversight. AI-enabled tools may support selected PV activities, but their value depends on validation, transparency, human oversight, and integration into compliant processes. At the same time, inspection readiness, vendor oversight, signal management, and RMP lifecycle management remain core pillars of effective PV operations.

At Excelya, we remain committed to walking this path alongside our clients. Our continued partnership with UBIQ pharma events reflects our belief that the future of pharmaceutical safety is built through shared expertise, open dialogue, and forward-looking collaboration.

Participants discussing pharmacovigilance during a workshop at UBIQ events

Frequently Asked Questions

What are UBIQ events?

UBIQ events are professional conferences dedicated to advancing pharmaceutical safety and adjacent life sciences disciplines. UBIQ industry events bring together Pharmacovigilance professionals, regulators, technology leaders, and CRO partners to share knowledge, debate trends, and strengthen the global PV community.

What was the focus of the 5th Pharmacovigilance & Drug Safety Conference in Madrid?

The 5th edition covered the full spectrum of modern PV. Topics included AI-enabled safety solutions, signal management, benefit-risk intelligence, audit and inspection preparedness, PV vendor management, SDEA maintenance, and continuous RMP lifecycle monitoring.

How is AI transforming drug safety and pharmacovigilance?

AI now powers concrete use cases across the PV value chain, from case intake automation to advanced signal detection and benefit-risk modeling. As a result, teams gain efficiency while improving the quality and timeliness of safety insights.

Why does Excelya sponsor UBIQ pharma events?

Excelya has sponsored the UBIQ Pharmacovigilance & Drug Safety Conference for three consecutive years. We believe these gatherings strengthen the PV community, accelerate innovation, and create the dialogue needed to shape the future of pharmaceutical safety events.

Who should attend UBIQ healthcare events?

UBIQ healthcare events are designed for pharmacovigilance professionals at every level, from operational specialists to senior strategists. Regulators, technology providers, and CRO partners also benefit from the cross-functional exchange these conferences foster.

Meet Us In Person